Post-Acute Sequelae of COVID-19 (PASC) in Pediatrics: Factors That Impact Symptom Severity and Referral to Treatment

被引:1
|
作者
Soprano, Catherine M. [1 ,2 ]
Ngo, Ryan [3 ]
Konys, Casey A. [4 ]
Bazier, Ashley [5 ]
Salamon, Katherine S. [1 ,2 ]
机构
[1] Nemours Childrens Hlth, Wilmington, DE 19803 USA
[2] Thomas Jefferson Univ, Sydney Kimmel Coll Med, Philadelphia, PA 19107 USA
[3] Bowdoin Coll, Brunswick, ME 04011 USA
[4] Lurie Childrens Hosp Chicago, Chicago, IL 60614 USA
[5] Indiana Univ, Sch Med, Indianapolis, IN 46805 USA
来源
CHILDREN-BASEL | 2023年 / 10卷 / 11期
关键词
PASC; COVID-19; pediatric; DISPARITIES;
D O I
10.3390/children10111805
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The post-acute sequelae of COVID-19 (PASC) is a complex condition. While there are emerging studies on its effects in adults, there is scarce research regarding the long-term effects of COVID-19 infection among youth. Several researchers have likened long-haul COVID-19 to chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) and postural orthostatic tachycardia syndrome (POTS). In adults, the prognosis for these diagnoses is less promising than that in youth; however, there is currently very little information available on the presentation of youth with PASC. A better understanding of the specific symptom presentation for youth diagnosed with PASC is necessary. Retrospective chart reviews were conducted collecting demographic data, COVID-19 symptoms and disease progression, and vaccination status. Additional data on referrals to a PASC treatment program and appointments attended were collected. Overall, data suggested that youth present with less severe PASC symptoms than adults, and the role of vaccination is unclear. These youth are often not referred to treatment programs. More exploration is necessary to continue to build an understanding of how best to aid youth diagnosed with PASC.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] No reduced serum serotonin levels in patients with post-acute sequelae of COVID-19
    Mathe, Philipp
    Goetz, Veronika
    Stete, Katarina
    Walzer, Dietrich
    Hilger, Hanna
    Pfau, Stefanie
    Hofmann, Maike
    Rieg, Siegbert
    Kern, Winfried V.
    INFECTION, 2025, 53 (01) : 463 - 466
  • [42] Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination
    Hulscher, Nicolas
    Procter, Brian C.
    Wynn, Cade
    McCullough, Peter A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [43] Identification of a Vulnerable Group for Post-Acute Sequelae of SARS-CoV-2 (PASC): People with Autoimmune Diseases Recover More Slowly from COVID-19
    Dreyer, Nancy
    Petruski-Ivleva, Natalia
    Albert, Lisa
    Mohamed, Damir
    Brinkley, Emma
    Reynolds, Matthew
    Toovey, Stephen
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 3941 - 3949
  • [44] Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
    Bisaccia, Giandomenico
    Ricci, Fabrizio
    Recce, Vittoria
    Serio, Antonio
    Iannetti, Giovanni
    Chahal, Anwar A.
    Stahlberg, Marcus
    Khanji, Mohammed Yunus
    Fedorowski, Artur
    Gallina, Sabina
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (11)
  • [45] Beneficial effects of Vitamin C and L-Arginine in the treatment of post-acute sequelae of COVID-19
    Santulli, Gaetano
    Trimarco, Valentina
    Trimarco, Bruno
    Izzo, Raffaele
    PHARMACOLOGICAL RESEARCH, 2022, 185
  • [46] Post-acute COVID-19 syndrome
    Szekanecz Zoltan
    Valyi-Nagy Istvan
    ORVOSI HETILAP, 2021, 162 (27) : 1067 - 1078
  • [47] Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment
    Sumi, Tomonari
    Harada, Kouji
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [48] Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC)
    Patterson, Bruce K.
    Yogendra, Ram
    Guevara-Coto, Jose
    Mora-Rodriguez, Rodrigo A.
    Osgood, Eric
    Bream, John
    Parikh, Purvi
    Kreimer, Mark
    Jeffers, Devon
    Rutland, Cedric
    Kaplan, Gary
    Zgoda, Michael
    FRONTIERS IN MEDICINE, 2023, 10
  • [49] COVID-19 Post-acute Sequelae Among Adults: 12 Month Mortality Risk
    Mainous, Arch G., III
    Rooks, Benjamin J.
    Wu, Velyn
    Orlando, Frank A.
    FRONTIERS IN MEDICINE, 2021, 8
  • [50] Low-dose naltrexone use for the management of post-acute sequelae of COVID-19
    Bonilla, Hector
    Tian, Lu
    Marconi, Vincent C.
    Shafer, Robert
    Mccomsey, Grace A.
    Miglis, Mitchel
    Yang, Philip
    Bonilla, Andres
    Eggert, Lauren
    Geng, Linda N.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 124